Immune hepatotoxicity screening method using hepatocytes derived from human stem cells

Patent metadata

Field	Value
Publication number	US-2017052172-A1
Application number	US-201615257338-A
Country	US
Kind code	A1
Filing date	Sep 6, 2016
Priority date	Mar 3, 2014
Publication date	Feb 23, 2017
Grant date	—

Abstract

The present invention relates to an immune hepatotoxicity screening method using hepatocytes derived from human stem cells. After hepatocytes differentiated from human stem cells and human hepatocytes are treated with ethanol, CCl 4 , and acetaminophen to induce immune hepatotoxicity, a hepatocellular immunotoxic material assay system is constructed in order to verify cytokines, chemokines, and lipid mediators, which are mediators secreted from the hepatocytes, and an immunotoxic material can be confirmed in the cells having the induced hepatotoxicity by using the system. Therefore, the immune hepatotoxicity screening method using hepatocytes derived from human stem cells can be favorably used.

First claim

1 . A hepatotoxicity inducing material screening method comprising the following steps:
1) treating the test material to the hepatocytes differentiated from human stem cells; and 2) measuring the level of apoptosis or proliferation inhibition in the hepatocytes of step 1).

2 . The hepatotoxicity inducing material screening method according to claim 1 , wherein the human stem cells of step 1) are human embryonic stem cells.

3 . The hepatotoxicity inducing material screening method according to claim 1 , wherein the differentiation of step 1) is induced by the following steps:
a) inducing the differentiation of human stem cells by culture; and b) culturing the differentiated cells above in a medium supplemented with a hepatocyte growth factor.

4 . A hepatotoxicity inducing material screening method comprising the following steps:
1) treating the test material to the hepatocytes differentiated from human stem cells; 2) obtaining the culture fluid of the hepatocytes of step 1) or the supernatant of the same; and 3) analyzing cytokines, chemokines, or lipid mediators in the culture fluid or the supernatant of step 2).

5 . The hepatotoxicity inducing material screening method according to claim 4 , wherein the human stem cells of step 1) are human embryonic stem cells.

6 . The hepatotoxicity inducing material screening method according to claim 4 , wherein the cytokine of step 3) is selected from the group consisting of IL-1β, IL-6, IL-10, IL-12, TNF-α, IFN-α, IFN-β, and TGF-β.

7 . The hepatotoxicity inducing material screening method according to claim 4 , wherein the chemokine of step 3) is selected from the group consisting of IL-8, IP-10, RANTES, MIP-1, and MCP.

8 . The hepatotoxicity inducing material screening method according to claim 4 , wherein the lipid mediator of step 3) is selected from the group consisting of prostaglandin and leukotriene.

9 . The hepatotoxicity inducing material screening method according to claim 1 , wherein the hepatotoxicity inducing material is selected from the group consisting of ethanol, CCl 4 , and acetaminophen.

10 . A hepatotoxicity inducing material detection kit comprising the hepatocytes differentiated from human stem cells.

11 . The hepatotoxicity inducing material detection kit according to claim 10 , wherein the hepatotoxicity inducing material is selected from the group consisting of ethanol, CCl 4 , and acetaminophen.

12 . The hepatotoxicity inducing material detection kit according to claim 10 , further comprising a detection reagent to detect the mediators secreted from the hepatocytes.

13 .- 14 . (canceled)

15 . The hepatotoxicity inducing material screening method according to claim 4 , wherein the hepatotoxicity inducing material is selected from the group consisting of ethanol, CCl 4 , and acetaminophen.

16 . The hepatotoxicity inducing material detection kit according to claim 12 , wherein the hepatotoxicity inducing material is selected from the group consisting of ethanol, CCl 4 , and acetaminophen.

Assignees

• Korea Advanced Inst Sci & Tech

Inventors

• Lee Seung-Hyo
• Kim Seyun
• Han Yong-Mahn

Classifications

• C12N5/067

  Hepatocytes · CPC title

• C12N2501/12

  Hepatocyte growth factor [HGF] · CPC title

• C12N2506/02

  from embryonic cells · CPC title

• G01N33/5067 Primary

  Liver cells · CPC title

• G01N2333/54

  Interleukins [IL] · CPC title